As stapled deals evolve to take all shapes and sizes, GPs and their advisors must continue to disclose their effect on pricing to LPs.
The increasing acceptance of GP-led deals has opened up opportunities in the smaller end of the market, but unique challenges arise when dealing with smaller funds.
Lumpiness, rather than sentiment, is why secondaries fundraising is down.
At a secondaries-themed breakfast we found that, unlike the pastries, changes to US tax rules are not going down well.
For all the debate it provokes, the conventional hurdle rate has remained stubbornly untouched since the ’80s.
Expect a document that gets into the weeds when the LP body issues its best practices for fund restructurings.
The secondaries market has come a long way; best practice around managing conflicts of interest has some way to go.
This year’s list welcomes a fresh spin-out, a direct secondaries player and niche specialists.
The UK’s Electra Private Equity may have ended its search for a buyer, but its five remaining assets remain in play. Will anyone be brave enough to buy them?
At the start of the year, Secondaries Investor made a number of predictions for 2018. We check to see how they are looking so far.